Balloon-Assisted Enteroscopic Treatment for Phytobezoar
Launched by SHANDONG UNIVERSITY · Mar 10, 2025
Trial Information
Current as of May 09, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new treatment method called balloon-assisted enteroscopic treatment for a condition known as phytobezoar, which refers to a type of blockage in the intestine caused by a mass of undigested plant material. The study reviews the experiences of patients who have received this treatment at our hospital to understand how safe and effective it is.
To be eligible for this study, patients needed to have undergone the balloon-assisted treatment for phytobezoar at our hospital, and their clinical data had to be complete for analysis. The trial is currently active, but it is not recruiting new participants at this time. Those who were treated can expect that their experiences will help researchers learn more about the benefits and risks of this treatment, ultimately improving care for future patients with similar conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Retrospectively collect data from patients who underwent balloon-assisted enteroscopic treatment for phytobezoar at our hospital.
- Exclusion Criteria:
- • Patients with incomplete clinical data.
About Shandong University
Shandong University is a prestigious research institution located in Jinan, China, renowned for its commitment to advancing medical and scientific knowledge through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment conducive to groundbreaking studies that address critical healthcare challenges. Shandong University actively engages in clinical research to evaluate new therapies and interventions, contributing to the global body of medical literature and enhancing patient care. Its dedicated team of researchers and clinicians ensures adherence to the highest ethical standards and regulatory compliance, positioning the university as a key player in the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jinan, Shandong, China
Patients applied
Trial Officials
Xiuli Zuo
Study Director
Qilu Hospital of Shandong University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported